A new market study, titled “Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022.: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022” has been featured on WiseGuyReports.
The report covers forecast and analysis for the rheumatology therapeutics market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the rheumatology therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rheumatology therapeutics market on a global level.
This report offers comprehensive coverage of global rheumatology therapeutics market along with, market trends, drivers, and restraints of rheumatology therapeutics market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the rheumatology therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.
The study provides a decisive view on the rheumatology therapeutics market by segmenting the market based on disease type, drug type, distribution channel, and region. All these segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022.
On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market. On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some of the key players operating in the rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi.
This report segments the rheumatology therapeutics market as follows:
Global Rheumatology Therapeutics Market: Disease Type Analysis Rheumatoid Arthritis Ankylosing spondylitis Osteoarthritis Lupus Gout Other
Global Rheumatology Therapeutics Market: Drug Type Analysis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Analgesics Disease Modifying Anti-Rheumatic Drugs (DMARDs) Corticosteroids Others
Global Rheumatology Therapeutics Market: Distribution Channel Analysis Retail Pharmacy Online Pharmacy Hospitals Other
Global Rheumatology Therapeutics Market: Regional Analysis North America The U.S. Canada Rest of North America Europe Germany UK France Italy Spain Russia Rest of Europe Asia Pacific China Japan India Australia Rest of Asia Pacific Latin America Mexico Brazil Argentina Rest of Latin America Middle East Africa Saudi Arabia UAE South Africa Qatar Rest of the Middle East and Africa
Table of Content
Chapter 1. Introduction
Chapter 2. Executive Summary
Chapter 3. Rheumatology Therapeutics market – Market Dynamics
Chapter 4. Global Rheumatology Therapeutics market – Competitive Landscape
Chapter 5. Global Rheumatology Therapeutics Market – Disease Type Analysis
Chapter 6. Global Rheumatology Therapeutics market – Drug Type Analysis
Chapter 7. Global Rheumatology Therapeutics Market : Distribution Channel Overview
Chapter 8. Global Rheumatology Therapeutics Market : Regional overview
Chapter 9. Company Profiles
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)